Gencove

Gencove is a genomics company founded by scientists and engineers with deep expertise in population genetics, bioinformatics, and sequencing technology. The company offers DNA-powered health insights to individual consumers, providing a genetic baseline that can be used alongside lab results, wearables, and lifestyle data to prioritize the health actions that matter most. Gencove's sequencing infrastructure was previously available only in research and enterprise settings — trusted by institutions such as Stanford and Oxford and pharmaceutical partners including GSK and Boehringer Ingelheim — and is now brought directly to consumers at an accessible price point.

At early access pricing of $49, Gencove ships an at-home buccal (cheek) swab collection kit, processes the sample using low-pass whole genome sequencing, and delivers personalized health insights along with a full raw data download. The entire process is designed to be simple: order a kit, mail back the sample with a prepaid return label, and receive results typically within 3–4 weeks of the sample arriving at the lab.

Health Insights and Coverage

• Gencove provides 9 DNA-based health insights across core prevention areas, with more insights and traits planned for future release.
• Heart and circulation: coronary artery disease, cholesterol, and atrial fibrillation.
• Metabolic and kidney: type 2 diabetes, obesity/BMI, and chronic kidney disease.
• Cancer predisposition: breast, colorectal, and prostate cancer risk.
• An ancestry module is included as an added benefit.
• Results are informational only, reflecting relative genetic risk compared to a reference population, and are intended as a starting point for conversations with a healthcare provider — not as a diagnostic tool.

How Polygenic Risk Scores Work

• Gencove uses Polygenic Risk Scores (PRS) to summarize the combined effect of many genetic variants — often thousands or millions — across the genome associated with a particular trait or condition.
• Rather than examining a single gene, PRS captures the cumulative influence of common, small-effect variants identified in large genome-wide association studies (GWAS).
• Each score places the individual on a risk spectrum relative to the general population.
• Reports include an at-a-glance summary of high risk versus not high risk results, recommended next steps for each result, and technical details and references for added context.

Sequencing vs. Genotyping

• Most consumer genetic tests use microarray chips that read only a small fraction of selected DNA markers; Gencove sequences the whole genome instead.
• Low-pass whole genome sequencing reads the entire genome rather than selected markers, supports reanalysis as science evolves, and performs consistently across diverse genetic backgrounds.
• Traditional microarray genotyping reads only chip-selected markers, may require a new test as science advances, and can perform differently across genetic backgrounds.

Pricing and What's Included

• A single $49 kit includes at-home collection, sequencing-powered analysis, predisposition insights, an ancestry module, and raw data download at any time.
• Gencove currently ships within the United States, with international availability planned for the future.
• Results are typically available 3–4 weeks after sample receipt; low-quality samples may take 4–6 weeks, with the lab making two processing attempts before requesting a new collection.

Privacy and Data Ownership

• Users own their genetic data entirely — Gencove does not claim ownership.
• Raw sequencing data can be downloaded or deleted at any time.
• Genetic data is stored securely with clear, understandable privacy practices.

Gencove also operates a separate research and enterprise platform (enterprise.gencove.com), making the same core sequencing technology available to research institutions and pharmaceutical organizations. The consumer product brings this same infrastructure to individuals looking to build a comprehensive, data-driven picture of their long-term health.